Skip to main content
C

Chunghwa Chemical Synthesis & Biotech Co., Ltd. — Investor Relations & Filings

Ticker · 1762 TW Manufacturing
Filings indexed 1,573 across all filing types
Latest filing 2025-05-29 Regulatory Filings
Country TW Taiwan
Listing TW 1762

About Chunghwa Chemical Synthesis & Biotech Co., Ltd.

https://www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司董事會通過委任第六屆薪資報酬委員會委員。
Regulatory Filings
2025-05-29 Chinese
公告本公司董事長及副董事長選任。
Regulatory Filings
2025-05-29 Chinese
公告本公司審計委員會委員任期屆滿異動。
Regulatory Filings
2025-05-29 Chinese
公告本公司股東常會決議解除董事及其代表人競業禁止之限制。
Regulatory Filings
2025-05-29 Chinese
公告本公司114年股東常會改選董事(含獨立董事)當選名單。
Regulatory Filings
2025-05-29 Chinese
公告本公司114年股東常會重要決議事項。
Regulatory Filings
2025-05-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.